Last updated: September 26, 2023
Sponsor: Psychiatric University Hospital, Zurich
Overall Status: Active - Recruiting
Phase
N/A
Condition
Schizophrenia And Schizoaffective Disorders (Pediatric)
Affective Disorders
Schizotypal Personality Disorder (Spd)
Treatment
Assertiveness Training Program (ATP)
Virtual Reality Avatar Therapy (VRAT)
Clinical Study ID
NCT04099940
VRAT- ATP
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Consistent acoustic hallucinations, with the presence of voices for at least twomonths.
- Participants are competent to give informed consent, as determined by the referringphysician or psychiatrist.
- German language proficiency as a native speaker or level B1 Common European Frameworkof Reference for Languages (CEFRL)
Exclusion
Exclusion Criteria:
- Current neurological disorder.
- Current substance use or withdrawal.
- Concomitant group psychotherapeutic intervention.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Assertiveness Training Program (ATP)
Phase:
Study Start date:
July 01, 2021
Estimated Completion Date:
December 31, 2025
Connect with a study center
Psychiatrische Universitätsklinik Zürich
Zürich, 8032
SwitzerlandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.